Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients

BACKGROUND: The outbreak of Coronavirus Disease 2019 (COVID-19) has been increasing rapidly. This disease causes an increase in proinflammatory cytokine production that leads to cytokine storm or cytokine release syndrome (CRS). Autologous activated platelet-rich plasma (aaPRP) contains various type...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Inflam
Autori principali: Karina, Karina, Rosliana, Iis, Rosadi, Imam, Sobariah, Siti, Christoffel, Louis Martin, Novariani, Rita, Rosidah, Siti, Fatkhurohman, Novy, Hertati, Yuli, Puspitaningrum, Nurlaela, Subroto, Wismo Reja, Afini, Irsyah, Ernanda, Difky
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi 2021
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285191/
https://ncbi.nlm.nih.gov/pubmed/34306612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/5531873
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi